Keith Lamont Cummings, Chief Financial Officer at PLIANT THERAPEUTICS, INC. (PLRX), sold 30,000 shares at $35.00 ($1.1M) on 2023-01-23, disclosed to the SEC on 2023-01-25.
Open-market sale of $1.1M PLRX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| PLRX | SELL | 2024-07-12 | $252K | — | Filing → |
| PLRX | SELL | 2024-01-19 | $337K | — | Filing → |
| PLRX | SELL | 2023-07-19 | $712K | — | Filing → |